Clinical trial
Does Caffeine Reduce Dipyridamole-Induced Protection Against…
NCT00430170 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00430170 |
|---|---|
| Title | Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury? |
| Official title | Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury? |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease, Ischemia-Reperfusion Injury |
| Intervention type | Drug |
| Interventions | Dipyridamole, caffeine |
| Enrollment | 20 |
| Start date | Jan 1, 2007 |
| Primary completion | Mar 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Feb 1, 2007 |
| Last update posted | Jul 29, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: